To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
ECOG-ACRIN Cancer Research Group
Recruiting ID
For more information, see NCT04597359
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Sinecatechins
Prostate Carcinoma
Nagi B Kumar, Jay W. Carlson, Tareq Al Baghdadi, Prem Sobti, Bryan A. Faller, Thomas E. Lad, James A. Wallace, Howard M. Gross, Debra M. Prow, Joshua Lukenbill, Rex B. Mowat, David M. King, Douglas J. Weckstein, Brandon Mullins, Charles O. Kim, Stephen J. Savage, Steven A. Madden, Lisa Bailey, Mike Cusnir, Robert L. Grubb, Bradley C. Ekstrand, Paul D. Maroni, Ross E. Krasnow, Izak Faiena, Isuru S. Jayaratna, Marc Bjurlin, Kelly L. Stratton, Ryan P. Kopp, Michael A. Liss, Inger L. Rosner, Shahzad Siddique, Matthew H. Hayn, Charles H. Shelton, James R. Mark, Alfredo I. Urdaneta, Site Public Contact

See list of participating sites